EMPLOYMENT AGREEMENTEmployment Agreement • October 18th, 2022 • TradeUP Acquisition Corp. • Blank checks • California
Contract Type FiledOctober 18th, 2022 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”), dated as of May 27, 2022 (the “Effective Date”), is made by and between Estrella Biopharma, Inc. a Delaware corporation (the “Company”), and Qian Yang (“Executive”). This Agreement shall govern the employment relationship between Executive and the Company from and after the Effective Date.
LICENSE AGREEMENTLicense Agreement • October 18th, 2022 • TradeUP Acquisition Corp. • Blank checks • Delaware
Contract Type FiledOctober 18th, 2022 Company Industry JurisdictionThis License Agreement (this “Agreement”), dated as of June 28, 2022 (the “Effective Date”), is entered into by and among, on the one hand, Eureka Therapeutics, Inc., a Delaware corporation (“Eureka US”), and Eureka Therapeutics (Cayman), Inc., an exempted company established under the laws of the Cayman Islands and a wholly-owned subsidiary of Eureka US (“Eureka Cayman”) (Eureka US and Eureka Cayman, collectively, “Eureka”), and, on the other hand, Estrella Biopharma, Inc., a Delaware corporation (“Licensee”). Eureka and Licensee are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
CONTRIBUTION AGREEMENTContribution Agreement • October 18th, 2022 • TradeUP Acquisition Corp. • Blank checks • Delaware
Contract Type FiledOctober 18th, 2022 Company Industry JurisdictionThis Contribution Agreement (this “Agreement”) is made and entered into as of June 28, 2022 (the “Effective Date”), by and between Eureka Therapeutics, Inc., a Delaware corporation (“Eureka”), and Estrella Biopharma, Inc., a wholly owned subsidiary of Eureka and a Delaware corporation (“Estrella”).
COLLABORATION AGREEMENTCollaboration Agreement • October 18th, 2022 • TradeUP Acquisition Corp. • Blank checks • Delaware
Contract Type FiledOctober 18th, 2022 Company Industry JurisdictionTHIS COLLABORATION AGREEMENT (this “Agreement”) is made effective as of October 29, 2021 (the “Effective Date”) by and between EUREKA THERAPEUTICS, INC., a Delaware corporation having an address at 5858 Horton Street, Suite 170, Emeryville, CA 94608 USA (“Eureka”), and IMUGENE LIMITED, a Australian corporation with a place of business at Suite 804, Level 8, 37 Bligh Street, Gadigal Country, Sydney, NSW, 2000 Australia (“Imugene”). Eureka and Imugene are each hereafter referred to individually as a “Party” and together as the “Parties.”
EMPLOYMENT AGREEMENTEmployment Agreement • October 18th, 2022 • TradeUP Acquisition Corp. • Blank checks • California
Contract Type FiledOctober 18th, 2022 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the "Agreement"), dated as of May 27, 2022 (the "Effective Date"), is made by and between Estrella Biopharma, Inc. a Delaware corporation (the "Company"), and Jiandong Xu ("Executive"). This Agreement shall govern the employment relationship between Executive and the Company from and after the Effective Date.
SERVICES AGREEMENTServices Agreement • October 18th, 2022 • TradeUP Acquisition Corp. • Blank checks • Delaware
Contract Type FiledOctober 18th, 2022 Company Industry JurisdictionThis Services Agreement (this “Agreement”), is made effective as the date of the last signature below, to be effective as of June 28, 2022 (the “Effective Date”), by and between Eureka Therapeutics, Inc., a Delaware corporation (“Eureka”) and Estrella Biopharma, Inc., a Delaware corporation (“Estrella”). Eureka and Estrella are referred to in this Agreement individually as a “Party” and collectively as the “Parties”.